Recommendations
28.

Provide patients who are having anticoagulation treatment with an ‘anticoagulant information booklet’ and an ‘anticoagulant alert card’ and advise them to carry the ‘anticoagulant alert card’ at all times.

Relative values of different outcomesMajor bleeding and the associated mortality and morbidity were considered the most important outcomes, as well as improving quality of life for patients by providing security and reassurance in case of an accident/emergency.
Trade off between clinical benefits and harmsPatients who are taking anticoagulants are at an increased risk of bleeding. In the event of major trauma or where there is difficulty in verbal communication, carrying an anticoagulant alert card can help to ensure that appropriate care is provided. Some patients may consider it inconvenient, but this is greatly outweighed by the benefits of carrying the card.
Economic considerationsNo economic evidence was found on this question. This recommendation is not expected to be associated with increased costs.
Quality of evidenceNon-applicable
Other considerationsThe GDG considered this to be an example of good medical practice.

To improve the adherence of carrying the card it is important to explain the rationale and the benefit of carrying the card to patients.
Recommendations are based on GDG consensus.

From: 11, Patient information

Cover of Venous Thromboembolic Diseases
Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing [Internet].
NICE Clinical Guidelines, No. 144.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.